Purpose of The Redwood Study
The purpose of The Redwood Study is to evaluate the safety and effectiveness of an investigational study drug in adults 18 to 75 years of age with Alpha-1 Liver Disease. The investigational study drug will be compared to a placebo; both groups will receive injections, but the placebo contains no active medication. This study may help researchers understand whether the study drug can reduce liver scarring caused by Alpha-1 Liver Disease.
Who May Qualify
If you or any of your family members have a confirmed or suspected diagnosis of Alpha-1 Liver Disease, you may be eligible for this study.
If you are interested, a participating research site can confirm a diagnosis of Alpha-1 Liver Disease, as well as other study criteria, to determine your eligibility.